Skandinaviska Enskilda Banken Ab (Publ) Eye Point Pharmaceuticals, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 71,515 shares of EYPT stock, worth $559,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,515
Previous 282,814
74.71%
Holding current value
$559,962
Previous $2.46 Million
76.79%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
154Shares Held
58.2MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$65.2 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$40.5 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$31.4 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$29.7 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$29.5 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $267M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...